Thus, S6K1-ERα consists of a positive feed-forward relationship in dictating breast cancer cell proliferation, which may be adopted as a therapeutic target for breast cancer with S6K1 amplification (Fig. 5C). Here, ESR1 is linked to breast carcinoma.